Rivercell raises $25M to build an AI virtual cell model
Rivercell has raised a $25M seed round led by HV, with HCVC, Alven and Bpifrance Digital Venture participating. The money will fund its data platform, a larger wet lab in Paris and its AI Virtual Cell programme, which the company describes as a world model of the cell that predicts how a cell changes after treatment. Rivercell says no dataset of comparable scale exists for how cells respond to drugs over time, so it plans to generate its own by filming living cells through each experiment and reading their gene activity, with the model choosing the next experiment and the company building its own instruments.
If the cell world model works, it could cut the number of physical lab experiments drug discovery needs, though no valuation or first-model timeline was given.

Paris start-up Rivercell has raised a $25M seed round to build an AI model that predicts how human cells respond to drugs and genetic changes. HV led the round, with HCVC, Alven and Bpifrance Digital Venture taking part, the company said on Wednesday.
The money will pay for Rivercell’s data platform, a bigger wet lab in Paris and the launch of its AI Virtual Cell programme. The company describes the model as a world model of the cell, meaning a simulation that predicts how a cell will change after a treatment.
#Rivercell#HV#HCVC#Alven#Bpifrance Digital Venture#AlphaFold#Bioptimus#Cardiologs